Prediction of extraprostatic cancer by serum [-2] pro prostate specific antigen in clinically localized prostate cancer

被引：0
|
作者：
Nakashima, Jun
Yamazaki, Keiichi
Kikuchi, Eiji
Miyajima, Akira
Nakagawa, Ken
Oya, Mototsugu
Ohigashi, Takashi
Murai, Masaru
机构：
来源：
JOURNAL OF UROLOGY | 2007年 / 177卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)31367-3
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：380 / 381
页数：2
相关论文
共 50 条
  • [31] Prostate-specific-antigen-density in the evaluation of lymph-node status in clinically localized prostate cancer
    Wolff, JM
    Boeckmann, W
    Effert, PJ
    Handt, S
    Jakse, G
    AKTUELLE UROLOGIE, 1996, 27 (03) : 136 - 140
  • [32] Evaluation of changes in prostate specific antigen in clinically localized prostate cancer managed without initial therapy - Comment
    Albertsen, PC
    JOURNAL OF UROLOGY, 1998, 159 (04): : 1246 - 1246
  • [33] Use of percent free prostate-specific antigen as a predictor of the pathological features of clinically localized prostate cancer
    Morote, J
    Encabo, G
    de Torres, IM
    EUROPEAN UROLOGY, 2000, 38 (02) : 225 - 229
  • [34] Can isoflavones influence prostate specific antigen serum levels in localized prostate cancer? A systematic review
    Ratha, P.
    Neumann, T.
    Schmidt, C. A.
    Schneidewind, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 287 - 287
  • [35] Extraprostatic biopsy improves the staging of localized prostate cancer
    Saliken, JC
    Gray, RR
    Donnelly, BJ
    Owen, R
    White, LJ
    Ali-Ridha, N
    So, B
    Ting, PT
    CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES, 2000, 51 (02): : 114 - 120
  • [36] Can Isoflavones Influence Prostate Specific Antigen Serum Levels in Localized Prostate Cancer? A Systematic Review
    Ratha, Prasan
    Neumann, Thomas
    Schmidt, Christian Andreas
    Schneidewind, Laila
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2021, 73 (03): : 361 - 368
  • [37] Prediction of local extent of disease by a combination of prostate specific antigen density, endorectal MRI and biopsy Gleason score in clinically localized prostate cancer
    Horiguchi, A
    Nakashima, J
    Horiguchi, Y
    Nakagawa, K
    Oya, M
    Ohigashi, T
    Marumo, K
    Murai, M
    JOURNAL OF UROLOGY, 2002, 167 (04): : 228 - 229
  • [38] The Percentage of [-2]Pro-Prostate-Specific Antigen and the Prostate Health Index Outperform Prostate-Specific Antigen and the Percentage of Free Prostate-Specific Antigen in the Detection of Clinically Significant Prostate Cancer and Can Be Used as Reflex Tests
    Garrido, Manuel M.
    Marta, Jose C.
    Bernardino, Rui M.
    Guerra, Joao
    Fernandes, Francisco
    Pereira, Maria H.
    Ribeiro, Ruy
    Holdenrieder, Stefan
    Pinheiro, Luis C.
    Guimaraes, Joao T.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2022, 146 (06) : 691 - 700
  • [39] Identification of clinically significant prostate cancer by prostate-specific antigen screening
    Smith, RP
    Malkowicz, SB
    Whittington, R
    VanArsdalen, K
    Tochner, Z
    Wein, A
    ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (11) : 1227 - 1230
  • [40] The use of prostate specific antigen density to predict clinically significant prostate cancer
    Yusim, Igor
    Krenawi, Muhammad
    Mazor, Elad
    Novack, Victor
    Mabjeesh, Nicola J.
    SCIENTIFIC REPORTS, 2020, 10 (01)
12345